Paper37814270
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M and 16 others. Mol Cancer, 2023. Cited by 584 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Papers, record 37814270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37814270
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Nanotechnology | |
| Drug Delivery Systems | |
| Drug Carriers | |
| Drug Compounding |
Source PubMed
References167
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31892180 | The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine. | Molecules | 2019 | https://conductscience.org/library/papers/31892180 | PubMed |
| 2 | 32580366 | Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis. | Polymers (Basel) | 2020 | https://conductscience.org/library/papers/32580366 | PubMed |
| 3 | 37376190 | Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37376190 | PubMed |
| 4 | 34492564 | Multiple drug resistance in hookworms infecting greyhound dogs in the USA. | Int J Parasitol Drugs Drug Resist | 2021 | https://conductscience.org/library/papers/34492564 | PubMed |
| 5 | 31956860 | Liposome mimicking polymersomes; A comparative study of the merits of polymersomes in terms of formulation and stability. | Int J Pharm X | 2020 | https://conductscience.org/library/papers/31956860 | PubMed |
| 6 | 34088867 | Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34088867 | PubMed |
| 7 | 22109657 | The golden age: gold nanoparticles for biomedicine. | Chem Soc Rev | 2012 | https://conductscience.org/library/papers/22109657 | PubMed |
| 8 | 16087878 | Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16087878 | PubMed |
| 9 | 28737672 | Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/28737672 | PubMed |
| 10 | 33301837 | Biomimetic nanoarchitecturing: A disguised attack on cancer cells. | J Control Release | 2021 | https://conductscience.org/library/papers/33301837 | PubMed |
| 11 | 32512027 | Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32512027 | PubMed |
| 12 | 34997888 | Protein nanoparticles directed cancer imaging and therapy. | Nano Converg | 2022 | https://conductscience.org/library/papers/34997888 | PubMed |
| 13 | 34051806 | Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34051806 | PubMed |
| 14 | 32972340 | Exosome as a Natural Gene Delivery Vector for Cancer Treatment. | Curr Cancer Drug Targets | 2020 | https://conductscience.org/library/papers/32972340 | PubMed |
| 15 | 33609621 | Polymeric micelles in cancer therapy: State of the art. | J Control Release | 2021 | https://conductscience.org/library/papers/33609621 | PubMed |
| 16 | 34633394 | Dual-targeting SERS-encoded graphene oxide nanocarrier for intracellular co-delivery of doxorubicin and 9-aminoacridine with enhanced combination therapy. | Analyst | 2021 | https://conductscience.org/library/papers/34633394 | PubMed |
| 17 | 35266686 | Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers. | ACS Nano | 2022 | https://conductscience.org/library/papers/35266686 | PubMed |
| 18 | 35280383 | MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35280383 | PubMed |
| 19 | 36876835 | The Interplay between Noncoding RNAs and p21 Signaling in Gastrointestinal Cancer: From Tumorigenesis to Metastasis. | Curr Pharm Des | 2023 | https://conductscience.org/library/papers/36876835 | PubMed |
| 20 | 19212324 | Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19212324 | PubMed |
Cited by390
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 584 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974481 | Artificial Intelligence-Enabled Nanomedicine in Precision Oncology: Diagnosis, Targeted Therapy, and Clinical Translation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42974481 | PubMed |
| 42829857 | Dual-targeted nanotechnology for gynaecological cancers: a comprehensive review of mechanisms and clinical potential. | Ann Med | 2026 | https://conductscience.org/library/papers/42829857 | PubMed |
| 42825065 | Carbon dots in cancer therapy: a novel approach to targeted drug delivery and reduced toxicity in gallbladder cancer. | Front Chem | 2026 | https://conductscience.org/library/papers/42825065 | PubMed |
| 42812214 | Distinct Internalization, Acoustic Behavior and Stress Responses to Nanobubbles in Pancreatic Cancer Cells. | Nanotheranostics | 2026 | https://conductscience.org/library/papers/42812214 | PubMed |
| 42794948 | Biomimetic Nanocarriers for Glioblastoma Therapy: Translational Advances and Strategic Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794948 | PubMed |
| 42719203 | 4D nanoimaging-guided smart therapeutics: spatiotemporal control of disease microenvironments. | RSC Adv | 2026 | https://conductscience.org/library/papers/42719203 | PubMed |
| 42701347 | Cetuximab-loaded self-assembled polymeric nanoparticles for the integrin-targeted therapy of glioblastoma. | JCIS Open | 2026 | https://conductscience.org/library/papers/42701347 | PubMed |
| 42680743 | A potassium-based single-atom catalyst enables acute lung injury immunotherapy in mice by inhibiting macrophage pyroptosis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42680743 | PubMed |
| 42646180 | Advances in Machine Learning-Enhanced PBPK Models for Brain-Targeted Drug Delivery via Nanocarriers: A Comprehensive Review. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42646180 | PubMed |
| 42633487 | From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery. | ADMET DMPK | 2026 | https://conductscience.org/library/papers/42633487 | PubMed |
| 42545662 | Sensitive detection of unopposed estrogen using estrogen receptor functionalized nanoprobes for cancer diagnosis. | Discov Nano | 2026 | https://conductscience.org/library/papers/42545662 | PubMed |
| 42530837 | Bacterial-based cancer therapy: mechanisms and therapeutic advances. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42530837 | PubMed |
| 42514913 | The Changing Landscape of Advanced Drug Delivery: From Passive Carriers to Intelligent Therapeutic Platforms. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514913 | PubMed |
| 42489717 | Induction of differential cytotoxicity and ROS-driven severe genomic DNA damage and intrinsic mitochondrial apoptosis by erbium oxide nanoparticles in p53-compromised human NSCLC cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42489717 | PubMed |
| 42479110 | Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42479110 | PubMed |
| 42455409 | Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization. | Discov Nano | 2026 | https://conductscience.org/library/papers/42455409 | PubMed |
| 42380588 | Advancements in RNA-based therapies from bench to bedside. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42380588 | PubMed |
| 42370018 | Surface-Engineered Selenium Nanoparticles with L-Asparagine and Tartaric Acid: Therapeutic Efficacy Against Breast Cancer and Bacterial Infections. | Iran J Med Sci | 2026 | https://conductscience.org/library/papers/42370018 | PubMed |
| 42365116 | Unveiling the potential of solid lipid nanoparticles of apigenin-Cu(II) coordinated nanocomplex in colon cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42365116 | PubMed |
| 42362822 | Repurposing Non-oncologic Drugs via Targeted Nanocarriers for Cancer Therapy: Mechanisms, Synergistic Combinations, and Clinical Translation. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/42362822 | PubMed |
Genes65
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37814270
GET https://conductscience.org/api/papers/v1/37814270/references?page=2